Analyzing Necessary Steps for Treating Patients with mCRC
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Bassel El-Rayes, MD, chief clinical research scientist, Winship Cancer Institute of Emory University, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer (mCRC).
The first thing is the importance of multidisciplinary care, says El-Rayes. Patients with mCRC need to be discussed in a tumor board and multiple specialties should be included in the discussion in order to form the best treatment plan. Physicians should be aware of all the advantages to different therapies available, such as surgery, radiofrequency ablation, microwave ablation, radiation, and transcatheter therapies.
Retrospective Data Demonstrates Efficacy of Regorafenib in mCRC
April 16th 2024During a Case-Based Roundtable® event, Madappa Kundranda, MD, PhD, discussed recent retrospective studies that compared outcomes between the available treatment options in patients with relapsed/refractory advanced colorectal cancer in the first article of a 2-part series.
Read More
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
